HK1024170A1 - Remedial composition for intraocular hypertension or glaucoma - Google Patents

Remedial composition for intraocular hypertension or glaucoma

Info

Publication number
HK1024170A1
HK1024170A1 HK00103455A HK00103455A HK1024170A1 HK 1024170 A1 HK1024170 A1 HK 1024170A1 HK 00103455 A HK00103455 A HK 00103455A HK 00103455 A HK00103455 A HK 00103455A HK 1024170 A1 HK1024170 A1 HK 1024170A1
Authority
HK
Hong Kong
Prior art keywords
glaucoma
intraocular hypertension
remedial composition
remedial
composition
Prior art date
Application number
HK00103455A
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of HK1024170A1 publication Critical patent/HK1024170A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK00103455A 1997-10-13 2000-06-08 Remedial composition for intraocular hypertension or glaucoma HK1024170A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27854097 1997-10-13
PCT/JP1998/004399 WO1999018969A1 (fr) 1997-10-13 1998-09-30 Composition curative de l'hypertension intraoculaire ou du glaucome

Publications (1)

Publication Number Publication Date
HK1024170A1 true HK1024170A1 (en) 2000-10-05

Family

ID=17598695

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00103455A HK1024170A1 (en) 1997-10-13 2000-06-08 Remedial composition for intraocular hypertension or glaucoma

Country Status (9)

Country Link
US (1) US6329426B1 (xx)
EP (1) EP0979652B1 (xx)
AT (1) ATE326972T1 (xx)
CA (1) CA2274708A1 (xx)
DE (1) DE69834638T2 (xx)
DK (1) DK0979652T3 (xx)
ES (1) ES2265166T3 (xx)
HK (1) HK1024170A1 (xx)
WO (1) WO1999018969A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5011548B2 (ja) * 1998-12-25 2012-08-29 株式会社アールテック・ウエノ 高眼圧症あるいは緑内障の処置用医薬組成物
AU2002243795A1 (en) * 2001-01-30 2002-08-12 Pharmaceutical Research Corporation Use of prostaglandin analogs for treatment of cardiac conditions
ATE422894T1 (de) * 2002-03-21 2009-03-15 Cayman Chem Co Prostaglandin f2 alpha analoga in kombination mit einem antimikrobiellen mittel zur behandlung von glaukom
JP2005519978A (ja) * 2002-03-28 2005-07-07 スキャンポ・アーゲー 高眼圧症および緑内障の処置方法
US20020168424A1 (en) * 2002-07-31 2002-11-14 Dr. Mohsen Shahinpoor Nitric oxide (NO) donor+cGMP-PDE5 inhibitor as a topical drug for glaucoma
US6864282B2 (en) * 2002-08-05 2005-03-08 Allergan, Inc. 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
US7320871B2 (en) * 2003-07-14 2008-01-22 Allergan, Inc. Human prostaglandin FP receptor variants and methods of using same
WO2007105691A1 (ja) * 2006-03-13 2007-09-20 R-Tech Ueno, Ltd. 水性組成物
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
EP2127638A1 (en) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
WO2017089980A1 (en) * 2015-11-26 2017-06-01 Cadila Healthcare Limited Dual ppar modulators for the treatment of diabetic retinopathy and diabetic eye diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209939B (en) 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
ES2317964T5 (es) * 1988-09-06 2015-02-20 Pfizer Health Ab Derivado de prostaglandina-F2alfa para el tratamiento de glaucoma o hipertensión ocular
GB8916944D0 (en) 1989-07-25 1989-09-13 Ici Plc Composite particle dispersions
ATE207360T1 (de) * 1992-03-19 2001-11-15 R Tech Ueno Ltd Behandlung von augenhochdruck mit betablockern und prostansäurederivaten
AU665287B2 (en) * 1992-12-21 1995-12-21 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
WO1997023225A1 (en) * 1995-12-22 1997-07-03 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop

Also Published As

Publication number Publication date
DK0979652T3 (da) 2006-09-11
CA2274708A1 (en) 1999-04-22
DE69834638D1 (de) 2006-06-29
US6329426B1 (en) 2001-12-11
EP0979652B1 (en) 2006-05-24
EP0979652A4 (en) 2003-05-14
DE69834638T2 (de) 2007-05-10
EP0979652A1 (en) 2000-02-16
ES2265166T3 (es) 2007-02-01
WO1999018969A1 (fr) 1999-04-22
ATE326972T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
SI1920764T2 (sl) Izopropilni estri fluprostenola za uporabo pri zdravljenju glavkoma in očesne hipertenzije
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
EP1224935A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
MX9805020A (es) Analogos de prostaglandinas de tetrahidrofurano substituido como hipotensores oculares.
CA2315829A1 (en) Angiostatic agents and compositions for controlling ocular hypertension
HK1024170A1 (en) Remedial composition for intraocular hypertension or glaucoma
AU5446299A (en) Medicinal compositions for treating eye diseases
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
AU5355498A (en) 15-fluoro prostaglandins as ocular hypotensives
AU5258698A (en) 15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
WO1998021182A3 (en) Use of cis-δ4 analogs of prostaglandins as ocular hypotensives
ATE289198T1 (de) Verwendung von flunarizin zur topischen behandlung ocularem hochdruck
SE9401087D0 (sv) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP1142576A4 (en) MEDICINAL COMPOSITION FOR TREATING THE INCREASED EYE PRESSURE OR GLAUCOMA

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150930